Top

Published in:

01-12-2024 | Research

A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer

Authors: Jennifer Gittleman, Joanna G. Cloutier, Elyse R. Park, Autumn Rasmussen, Colin Ponzani, Andrea H. Weinberger, Jamie S. Ostroff, Giselle Perez

Published in: Supportive Care in Cancer | Issue 12/2024

Abstract

Purpose

Among patients with cancer, tobacco use remains high. Nearly half who report smoking at diagnosis continue to smoke following diagnosis, and use of smoking cessation medication remains low. This study explores attitudes, barriers, and preferences for smoking cessation medication among patients enrolled in a tobacco treatment trial in the context of cancer care.

Methods

This is a secondary qualitative analysis of the Smokefree Support Study. Of 221 participants who completed the 6-month follow-up survey, n = 72 participants were randomly selected for an exit interview. Interviews were conducted using a semi-structured interview guide, recorded, transcribed, and individually coded using NVivo 11 until high interrater reliability was reached (Kappa > 0.86).

Results

Participants (55.6% female) were predominantly White (83.3%) and on average 60 years old. Many participants held negative beliefs about smoking cessation medications, primarily concerns about safety and side effects in the context of cancer treatment. Lack of understanding interactions with ongoing chemotherapy and access were the most common barriers reported by those who did not use cessation medication during the study. For those who did use medication during the study, positive outcomes included craving reduction, ease of use and access, and psychological benefits.

Conclusion

The findings suggest a knowledge gap in the safety and effectiveness of smoking cessation medications, specifically in relation to cancer care. Addressing this knowledge gap may increase medication uptake, adherence, and quit rates. Cancer care providers are seen as instrumental in emphasizing the importance and safety of smoking cessation medications as well as patient access concerns.

Implications

Tobacco use among patients with cancer remains high and has serious clinical implications. Tobacco cessation is associated with decreased treatment-related toxicity, decreased risk of second primary cancers, and increased survival rates. Smoking cessation medications are effective, yet patients with cancer have low usage rates. Elucidating reasons associated with smoking cessation medication nonadherence will assist cancer care providers in better addressing factors that increase adherence rates.

National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking—50 years of progress: a report of the surgeon general. Centers for Disease Control and Prevention (US); 2014. Accessed January 8, 2024. http://www.ncbi.nlm.nih.gov/books/NBK179276/

Vidrine JI, Simmons VN, Vidrine DJ. Improving smoking cessation support for patients with cancer. JCO Oncol Pract. Published online January 5, 2024:OP.23.00708. https://doi.org/10.1200/OP.23.00708

Feuer Z, Michael J, Morton E et al (2022) Systematic review of smoking relapse rates among cancer survivors who quit at the time of cancer diagnosis. Cancer Epidemiol 80:102237. https://doi.org/10.1016/j.canep.2022.102237CrossRefPubMedPubMedCentral

NCCN (2022) Smoking Cessation. National Comprehensive Cancer Network

U.S. National Cancer Institute. Treating smoking in cancer patients: an essential component of cancer care. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2022.

Cinciripini PM, Karam-Hage M, Kypriotakis G et al (2019) Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open 2(9):e1912251. https://doi.org/10.1001/jamanetworkopen.2019.12251CrossRefPubMedPubMedCentral

Croyle RT, Morgan GD, Fiore MC (2019) Addressing a core gap in cancer care — the NCI Moonshot Program to help oncology patients stop smoking. N Engl J Med 380(6):512–515. https://doi.org/10.1056/NEJMp1813913CrossRefPubMedPubMedCentral

Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J (2022) Treatment of tobacco smoking: A review. JAMA 327(6):566. https://doi.org/10.1001/jama.2022.0395CrossRefPubMed

Shang XEF, Guo K et al (2023) Effectiveness and safety of varenicline for smoking cessation: An overview and meta-analysis. J Addict Med 17(5):536–543. https://doi.org/10.1097/ADM.0000000000001171CrossRefPubMed

10.

Carroll AJ, Kim K, Miele A et al (2019) Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking. Addict Behav 95:206–210. https://doi.org/10.1016/j.addbeh.2019.04.003CrossRefPubMedPubMedCentral

11.

Crawford G, Weisbrot J, Bastian J et al (2019) Predictors of varenicline adherence among cancer patients treated for tobacco dependence and its association with smoking cessation. Nicotine Tob Res 21(8):1135–1139. https://doi.org/10.1093/ntr/nty133CrossRefPubMed

12.

Schnoll R, Leone F, Veluz-Wilkins A et al (2019) A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence. Psychooncology 28(3):561–569. https://doi.org/10.1002/pon.4978CrossRefPubMedPubMedCentral

13.

Burris JL, Borger TN, Shelton BJ et al (2022) Tobacco use and tobacco treatment referral response of patients with cancer: implementation outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract 18(2):e261–e270. https://doi.org/10.1200/OP.20.01095CrossRefPubMed

14.

Schiavon S, Davies E, Mildrum Chana S et al (2022) Oncology patient smoking cessation treatment preferences: perceptions across former and current cigarette smokers. J Cancer Educ 37(6):1975–1981. https://doi.org/10.1007/s13187-021-02068-1CrossRefPubMed

15.

Crawford G, Jao N, Peng AR et al (2018) The association between self-reported varenicline adherence and varenicline blood levels in a sample of cancer patients receiving treatment for tobacco dependence. Addict Behav Rep 8:46–50. https://doi.org/10.1016/j.abrep.2018.06.006CrossRefPubMedPubMedCentral

16.

Park ER, Perez GK, Regan S et al (2020) Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. JAMA 324(14):1406. https://doi.org/10.1001/jama.2020.14581CrossRefPubMedPubMedCentral

17.

Puleo GE, Borger T, Bowling WR, Burris JL (2022) The state of the science on cancer diagnosis as a “teachable moment” for smoking cessation: a scoping review. Nicotine Tob Res 24(2):160–168. https://doi.org/10.1093/ntr/ntab139CrossRefPubMed

18.

Pacek LR, McClernon FJ, Bosworth HB (2018) Adherence to pharmacological smoking cessation interventions: a literature review and synthesis of correlates and barriers. Nicotine Tob Res 20(10):1163–1172. https://doi.org/10.1093/ntr/ntx210CrossRefPubMed

19.

Park ER, Ostroff JS, Perez GK et al (2016) Integrating tobacco treatment into cancer care: study protocol for a randomized controlled comparative effectiveness trial. Contemp Clin Trials 50:54–65. https://doi.org/10.1016/j.cct.2016.07.016CrossRefPubMedPubMedCentral

20.

Miles MB and Huberman AM (1994) Qualitative data analysis: an expanded sourcebook. 2. ed., [Nachdr.]. Sage

21.

Catz SL, Jack LM, McClure JB et al (2011) Adherence to varenicline in the COMPASS Smoking Cessation Intervention Trial. Nicotine Tob Res 13(5):361–368. https://doi.org/10.1093/ntr/ntr003CrossRefPubMedPubMedCentral

22.

Kushnir V, Sproule BA, Cunningham JA (2017) Mailed distribution of free nicotine patches without behavioral support: PrediCTORS OF USE and cessation. Addict Behav 67:73–78. https://doi.org/10.1016/j.addbeh.2016.12.008CrossRefPubMed

23.

Voci SC, Zawertailo LA, Hussain S, Selby PL (2016) Association between adherence to free nicotine replacement therapy and successful quitting. Addict Behav 61:25–31. https://doi.org/10.1016/j.addbeh.2016.05.012CrossRefPubMed

24.

Yingst JM, Veldheer S, Hrabovsky S, Sciamanna C, Foulds J (2015) Reasons for non-adherence to nicotine patch therapy during the first month of a quit attempt. Int J Clin Pract 69(8):883–888. https://doi.org/10.1111/ijcp.12644CrossRefPubMed

25.

Incirliova District Health Directorate, Aydin, Turkey, Aksel O, Kucuktepe N, et al. Providing free access to smoking cessation medications: does it have an impact on the treatment adherence and success of smoking cessation? Turk Thorac J. 2021;22(3):224–230. https://doi.org/10.5152/TurkThoracJ.2021.20124

26.

Karam-Hage M, Cinciripini PM, Gritz ER (2014) Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin 64(4):272–290. https://doi.org/10.3322/caac.21231CrossRefPubMedPubMedCentral

27.

Burns EK, Levinson AH (2008) Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prev Med 34(3):212–215. https://doi.org/10.1016/j.amepre.2007.11.010CrossRefPubMed

28.

Suehs BT, Davis C, Galaznik A, Joshi AV, Zou KH, Patel NC (2014) Association of out-of-pocket pharmacy costs with adherence to varenicline. J Manag Care Pharm 20(6):592–600. https://doi.org/10.18553/jmcp.2014.20.6.592CrossRef

29.

Van Boven JFM, Vemer P (2015) Higher adherence during reimbursement of pharmacological smoking cessation treatments. Nicotine Tob Res. Published online March 16, 2015:ntv064. https://doi.org/10.1093/ntr/ntv064

30.

Levy DE, Regan S, Perez GK et al (2022) Cost-effectiveness of implementing smoking cessation interventions for patients with cancer. JAMA Netw Open 5(6):e2216362. https://doi.org/10.1001/jamanetworkopen.2022.16362CrossRefPubMedPubMedCentral

31.

Cheng H, Yang Z, Dong B et al (2013) Chemotherapy-induced prospective memory impairment in patients with breast cancer. Psychooncology 22(10):2391–2395. https://doi.org/10.1002/pon.3291CrossRefPubMed

32.

Henderson FM, Cross AJ, Baraniak AR (2019) ‘A new normal with chemobrain’: experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open 6(1):205510291983223. https://doi.org/10.1177/2055102919832234CrossRef

33.

Ren X, Boriero D, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta BBA - Mol Basis Dis. 2019;1865(6):1088–1097. https://doi.org/10.1016/j.bbadis.2019.02.007

34.

Davidson SM, Boldt RG, Louie AV (2018) How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation. Curr Oncol 25(3):226–230. https://doi.org/10.3747/co.25.3921CrossRefPubMedPubMedCentral

35.

Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR (2013) Smoking at diagnosis and survival in cancer patients. Int J Cancer 132(2):401–410. https://doi.org/10.1002/ijc.27617CrossRefPubMed

36.

Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR (2015) Identifying targeted strategies to improve smoking cessation support for cancer patients. J Thorac Oncol 10(11):1532–1537. https://doi.org/10.1097/JTO.0000000000000659CrossRefPubMed

37.

Shiffman S, Ferguson SG, Hellebusch SJ (2007) Physicians’ counseling of patients when prescribing nicotine replacement therapy. Addict Behav 32(4):728–739. https://doi.org/10.1016/j.addbeh.2006.06.021CrossRefPubMed

38.

Croghan IT, Hurt RD, Ebbert JO et al (2010) Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. J Public Health 18(1):59–68. https://doi.org/10.1007/s10389-009-0277-2CrossRefPubMed

39.

Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H (2011) Disparities between blacks and whites in tobacco and lung cancer treatment. Oncologist 16(10):1428–1434. https://doi.org/10.1634/theoncologist.2011-0114CrossRefPubMedPubMedCentral

40.

Ryan KK, Garrett-Mayer E, Alberg AJ, Cartmell KB, Carpenter MJ (2011) Predictors of cessation pharmacotherapy use among Black and Non-Hispanic White smokers. Nicotine Tob Res 13(8):646–652. https://doi.org/10.1093/ntr/ntr051CrossRefPubMedPubMedCentral

41.

Kumar P, Gareen IF, Lathan C et al (2016) Racial differences in tobacco cessation and treatment usage after lung screening: an examination of the National Lung Screening Trial. Oncologist 21(1):40–49. https://doi.org/10.1634/theoncologist.2015-0325CrossRefPubMed

42.

Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP (2006) Successes and failures of the teachable moment: Smoking cessation in cancer patients. Cancer 106(1):17–27. https://doi.org/10.1002/cncr.21598CrossRefPubMed

43.

Burke L, Miller LA, Saad A, Abraham J (2009) Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract 5(1):6–9. https://doi.org/10.1200/JOP.0912001CrossRefPubMedPubMedCentral

44.

Guimond AJ, Croteau VA, Savard MH, Bernard P, Ivers H, Savard J (2017) Predictors of smoking cessation and relapse in cancer patients and effect on psychological variables: an 18-month observational study. Ann Behav Med 51(1):117–127. https://doi.org/10.1007/s12160-016-9834-4CrossRefPubMed

45.

Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI (2016) Readiness of lung cancer screening sites to deliver smoking cessation treatment: current practices, organizational priority, and perceived barriers. Nicotine Tob Res 18(5):1067–1075. https://doi.org/10.1093/ntr/ntv177CrossRefPubMed

Title: A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer
Authors: Jennifer Gittleman
Joanna G. Cloutier
Elyse R. Park
Autumn Rasmussen
Colin Ponzani
Andrea H. Weinberger
Jamie S. Ostroff
Giselle Perez
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 12/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-024-09030-z

Effectiveness of ePRO-based symptom management for cancer patients: a systematic review and meta-analysis of randomized controlled studies

Anxiety
Review

Unapproved and unproven cancer treatments in patients admitted to palliative care units

Palliative Care Unit
Research

Point-of-care ultrasound in palliative medicine residency programs: report of a national survey and local workshop

Palliative Medicine
Research

Letter to the Editor: Exploring the integration of dentistry within a multidisciplinary palliative care team: does bedside dental care improve quality of life and symptom burden in inpatient palliative care patients?

Correspondence

Correction to: Abstracts for MASCC/AFSOS/ISOO Annual Meeting 2024

Correction

Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample

Open Access
Cervical Cancer
Research

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Targeted Therapy
On-demand webinar

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Keynote series | Spotlight on menopause

Springer Medicine

A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer

Abstract

Purpose

Methods

Results

Conclusion

Implications

Other articles of this Issue 12/2024

Effectiveness of ePRO-based symptom management for cancer patients: a systematic review and meta-analysis of randomized controlled studies

Unapproved and unproven cancer treatments in patients admitted to palliative care units

Point-of-care ultrasound in palliative medicine residency programs: report of a national survey and local workshop

Letter to the Editor: Exploring the integration of dentistry within a multidisciplinary palliative care team: does bedside dental care improve quality of life and symptom burden in inpatient palliative care patients?

Correction to: Abstracts for MASCC/AFSOS/ISOO Annual Meeting 2024

Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications

Please log in to get access to this content